24.03

1.95% -0.47

Elanco Animal Health Inc (ELAN)

Overview News Price History Option Chain Financials Discussions Forecast

Elanco Animal Health Inc stock is traded at $24.03, with a volume of 384.06K. It is down -1.95% in the last 24 hours and up +8.60% over the past month. Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.

Previous Close:

$24.50

Open:

$24.37

24h Volume:

384.06K

Relative Volume:

0.07

Market Cap:

$12.00B

Revenue:

$4.89B

Net Income/Loss:

$-242.00M

P/E Ratio:

-49.14

EPS:

-0.489

Net Cash Flow:

$315.00M

1W Performance:

+0.47%

1M Performance:

+8.60%

6M Performance:

+2.83%

1Y Performance:

+26.10%

1-Day Range:

$23.94

$24.38

1-Week Range:

$23.74

$25.07

52-Week Range:

$18.22

$27.98

Elanco Animal Health Inc Stock (ELAN) Company Profile

Name

Elanco Animal Health Inc

Sector

Healthcare (1079)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

877-352-6261

Address

450 ELANCO CIRCLE, INDIANAPOLIS

Employee

9,900

Twitter

@Elanco

Next Earnings Date

2026-08-05

Latest SEC Filings

ELAN's Discussions on Twitter

Compare ELAN vs TAK, TEVA, HLN, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ELAN Elanco Animal Health Inc	24.02	12.24B	4.89B	-242.00M	315.00M	-0.489
TAK Takeda Pharmaceutical Co Adr	18.39	58.92B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.50	42.37B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.285	42.22B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	74.72	31.33B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	498.73	20.91B	3.17B	1.29B	1.01B	27.09

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-15-26	Initiated	Citigroup	Buy
Jan-22-26	Upgrade	Piper Sandler	Neutral → Overweight
Dec-09-25	Initiated	Barclays	Overweight
Nov-21-25	Initiated	KeyBanc Capital Markets	Overweight
Nov-19-25	Upgrade	Argus	Hold → Buy
Oct-07-25	Upgrade	JP Morgan	Neutral → Overweight
Jul-17-25	Upgrade	Leerink Partners	Market Perform → Outperform
Jun-26-25	Upgrade	William Blair	Mkt Perform → Outperform
Dec-09-24	Initiated	UBS	Buy
Dec-02-24	Initiated	Leerink Partners	Market Perform
Sep-19-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-05-24	Upgrade	Stifel	Hold → Buy
Dec-19-23	Initiated	Jefferies	Buy
Dec-15-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Dec-07-23	Initiated	Exane BNP Paribas	Outperform
Apr-20-23	Upgrade	Barclays	Equal Weight → Overweight
Aug-18-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-16-22	Downgrade	JP Morgan	Overweight → Neutral
Jul-21-22	Downgrade	Goldman	Buy → Sell
Jul-12-22	Initiated	Piper Sandler	Neutral
Nov-18-21	Initiated	Morgan Stanley	Overweight
Oct-28-21	Downgrade	Stifel	Buy → Hold
Aug-05-21	Resumed	Credit Suisse	Outperform
Jun-15-21	Upgrade	Cleveland Research	Underperform → Neutral
May-11-21	Upgrade	Barclays	Underweight → Equal Weight
May-11-21	Upgrade	Gabelli & Co	Hold → Buy
Apr-15-21	Initiated	Stifel	Buy
Mar-22-21	Downgrade	Gabelli & Co	Buy → Hold
Feb-26-21	Upgrade	Credit Suisse	Neutral → Outperform
Dec-09-20	Downgrade	Argus	Buy → Hold
Nov-09-20	Downgrade	Barclays	Overweight → Underweight
Aug-20-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Aug-13-20	Resumed	Credit Suisse	Neutral
Aug-04-20	Resumed	Goldman	Buy
Jul-27-20	Downgrade	Cleveland Research	Neutral → Underperform
Apr-02-20	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-10-20	Initiated	Raymond James	Mkt Perform
Dec-19-19	Upgrade	BofA/Merrill	Neutral → Buy
Nov-07-19	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-23-19	Initiated	Barclays	Overweight
Aug-26-19	Downgrade	BofA/Merrill	Buy → Neutral
Aug-15-19	Upgrade	UBS	Sell → Neutral
May-23-19	Initiated	Guggenheim	Neutral
Mar-18-19	Upgrade	BofA/Merrill	Neutral → Buy
Mar-13-19	Resumed	Morgan Stanley	Equal-Weight
Feb-12-19	Initiated	William Blair	Mkt Perform
Jan-23-19	Initiated	UBS	Sell
Jan-15-19	Initiated	Argus	Buy
Oct-15-18	Initiated	Morgan Stanley	Equal-Weight

View All

Elanco Animal Health Inc Stock (ELAN) Latest News

Sep 04, 2026

Elanco Animal Health Stock Price Forecast. Should You Buy ELAN? - StockInvest.us

Sep 04, 2026

Pharma clinical research firm eyes former Elanco building in Greenfield - Indianapolis Business Journal

Sep 02, 2026

Elanco Animal Health (ELAN) Institutional Ownership 2026 $ELAN - MarketBeat

Sep 02, 2026

Aug 31, 2026

Elanco Scales Biologics Capabilities With Expansion of Kansas Manufacturing Facility - marketscreener.com

Aug 31, 2026

Aug 26, 2026

Elanco Says Demand for Its New Dog Treatment Is Twice What Was Expected - Stock Titan

Aug 26, 2026

Aug 25, 2026

Elanco (NYSE: ELAN) EVP now holds 9,770 deferred units - Stock Titan

Aug 25, 2026

Elanco (NYSE: ELAN) CFO holds 141.8242 deferred stock units - Stock Titan

Aug 25, 2026

Aug 24, 2026

Elanco Animal Health (ELAN) Stock Analysis: Unlocking a 30% Upside Potential with Strong Buy Ratings - DirectorsTalk Interviews

Aug 24, 2026

Aug 21, 2026

Elanco Animal Health (NYSE:ELAN) Director Lawrence Erik Kurzius Purchases 40,000 Shares - MarketBeat

Aug 21, 2026

Elanco director Kurzius buys $935,920 in company stock - Investing.com

Aug 21, 2026

Elanco Animal Health Director Purchased Shares Worth Over $935K - TradingView

Aug 21, 2026

Elanco (NYSE: ELAN) director buys 40K shares, stake now 188,647 - Stock Titan

Aug 21, 2026

Danske Bank A S Makes New $14.35 Million Investment in Elanco Animal Health Incorporated $ELAN - MarketBeat

Aug 21, 2026

Aug 20, 2026